510(k) K895377
K895377 is an FDA 510(k) premarket notification submitted by Kallestad Diag, A Div. of Erbamont, Inc. for the device "QM300 CERULOPLASMIN ANTIBODY PACK". The FDA issued a decision of Substantially Equivalent on September 21, 1989. The device falls under product code DDB (Ceruloplasmin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5210. Kallestad Diag, A Div. of Erbamont, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 21, 1989
- Date Received
- August 30, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Ceruloplasmin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5210
- Review Panel
- IM
- Submission Type